Has Angela Casey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,616 in general payments to Angela Casey, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Casey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Casey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Casey, MD

MOHS-Micrographic Surgery · Westerville, OHNPI 1467572743

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $803, 9.6 times the $84 reported in 2019.

$1,616in general payments, 2019–2025

Across 50 payments — averaging $32.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arcutis Biotherapeutics, Inc.$215
Regeneron Healthcare Solutions, Inc.$208
Lilly USA, LLC$178
Sun Pharmaceutical Industries Inc.$161
E.r. Squibb & Sons, L.L.C.$147
AbbVie$143
plus $565 from 17 others

What the payments were for

Food & beverage$1,616100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arcutis Biotherapeutics, Inc.	3	$215
Regeneron Healthcare Solutions, Inc.	6	$208
Lilly USA, LLC	8	$178
Sun Pharmaceutical Industries Inc.	3	$161
E.r. Squibb & Sons, L.L.C.	2	$147
AbbVie	2	$143
Dermavant Sciences, Inc.	2	$100
Sanofi	2	$56
Novartis	2	$52
LEO Pharma Inc.	2	$51
Galderma Laboratories, L.p.	3	$38
Johnson & Johnson	2	$32
Genentech USA, Inc.	2	$31
Teva Pharmaceuticals USA, Inc.	2	$30
Botanix SB Inc	1	$28
Revance Therapeutics, Inc.	1	$24
UCB, Inc.	1	$23
Almirall LLC	1	$20
Boehringer Ingelheim	1	$19
Incyte Corporation	1	$16
Bristol Myers Squibb	1	$16
Amgen	1	$15
Organon	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ILUMYA$121
Skyrizi$116
DUPIXENT$112

How this compares

$1,616 in reported general payments places this provider in the 55th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$941,219

Medicare patients

397

Services billed

1,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	141	$967
Gentamicin Sulfate	13	$368
Cephalexin	57	$271
Mupirocin	36	$187
ValacyclovirValacyclovir Hcl	16	$130
Ciprofloxacin Hcl	14	$86
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$27

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Westerville

Peter SelineWesterville$2K
Brian BiernatWesterville$784
Maralyn SeavoltWesterville$36
Jorge Garcia ZuazagaConcord Township$149K
Morgan HottWarren$16K
Jennifer PopovskyMedina$15K
Justin WoodhouseMayfield Heights$7K
Mihir ShahWestlake$5K
Allison MoosallyFairlawn$5K
Kathleen NemerAthens$3K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →